Attovia Therapeutics, Inc 10-Q for FY2026 Q2
Attovia Therapeutics, Inc. (ATTO)
10-Q
2026-09-02
For: 2026-06-30
View Original
Added on
September 02, 2026
About this 10-Q
Attovia Therapeutics, Inc filed this 10-Q on September 2, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $450K
- compared with $0 a year earlier
- Net loss
- $20.69M
- compared with a net loss of $14.44M a year earlier
- Diluted EPS
- -$4.88
- compared with -$3.71 a year earlier